Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

NCT00673751 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: GLP-2
DRUG: Placebo

Sponsor

Glostrup University Hospital, Copenhagen